image
Healthcare - Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
CASH FLOW STATEMENT
2.77 B OPERATING CASH FLOW
-7.32%
-2.68 B INVESTING CASH FLOW
-29.20%
361 M FINANCING CASH FLOW
116.81%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Royalty Pharma plc
image
Net Income 1.33 B
Depreciation & Amortization 0
Capital Expenditures 0
Stock-Based Compensation 2.34 M
Change in Working Capital 53.4 M
Others 1.44 B
Free Cash Flow 2.77 B

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income 1 330.8 1 134.8 230.1 1 241.2 1 702.0 2 461.4 1 517.9 1 343.2
Depreciation & Amortization 0 0 5.7 23.0 23.1 23.9 33.3 33.3
Deferred Income Tax 0 0 0 (1 522.4) 65.5 0 0 0
Stock Based Compensation 2.3 2.4 2.2 2.4 5.4 0 0 0
Other Operating Activities 1 382.4 (1 349.9) 1 873.4 2 289.6 2 122.7 855.4 1 629.6 1 517.5
Change in Working Capital 53.4 3 200.6 32.7 (16.3) (1 884.0) (1 673.5) (1 562.4) (1 475.6)
Cash From Operations 2 769.0 2 987.8 2 144.0 2 017.5 2 034.6 1 667.2 1 618.3 1 418.3
INVESTING CASH FLOW
Capital Expenditures 0 0 2 041.2 0.5 2 197.0 (1 721.3) 269.6 (2 290.7)
Other Items (2 678.1) (2 072.8) (3 070.6) (1 870.8) (4 956.0) (394.9) 33.8 703.0
Cash From Investing Activities (2 678.1) (2 072.8) (1 029.4) (1 870.3) (2 759.0) (2 116.1) 303.4 (1 587.7)
FINANCING CASH FLOW
Common Stock Repurchased (229.7) (304.8) 0 0 0 (4.3) 0 0
Total Debt Repaid 1 471.2 (1 000.0) 0 1 272.5 680.6 (294.0) (294.0) 907.0
Dividends Paid (376.5) (358.3) (333.3) (285.2) (397.8) (739.3) (814.4) (735.2)
Other Financing Activities (504.0) (485.7) (611.5) (602.2) (704.4) (154.1) (270.7) (295.1)
Cash From Financing Activities 361.1 (2 148.8) (944.9) 385.1 1 487.0 (1 191.6) (1 379.1) (123.3)
CHANGE IN CASH
Net Change In Cash 452.0 (1 233.7) 169.7 532.4 763.0 (1 640.5) 542.6 (292.6)
FREE CASH FLOW
Free Cash Flow 2 769.0 2 987.8 4 185.1 2 018.1 4 231.6 (54.1) 1 887.9 (872.4)